Budesonide
- Product NDC
- 16714-019
- 11-digit product format
- 167140019
- Labeler code
- 16714
- Product ID
- 16714-019_9bbd2475-b4f2-4776-b59e-add17f17984b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Budesonide
- Dosage form
- INHALANT
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA205710
- Marketing category
- ANDA
- Marketing start
- 2020-11-11
- Marketing end
- 0000-00-00
- Substance
- BUDESONIDE
- Active strength
- 1 mg/2mL
- Pharmacologic classes
- Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-019 | BUDESONIDE INHALATION SUSPENSION (BUDESONIDE) INHALANT [NORTHSTAR RXLLC] | 3 | Legacy NDC | 20240921_ba9bbecc-5d2e-4b21-9934-23bb919e7623.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-019-30 | 16714001930 | 6 POUCH in 1 CARTON (16714-019-30) > 5 AMPULE in 1 POUCH (16714-019-05) > 2 mL in 1 AMPULE | 6 pouch | 2020-11-11 | 0000-00-00 | No | No | Current |